Skip to content

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01214005
Acronym
WREN
Enrollment
60
Registered
2010-10-04
Start date
2009-06-30
Completion date
2012-02-29
Last updated
2012-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder, Schizophrenia

Keywords

nicotine, reinforcement, craving, relapse

Brief summary

This project tests two hypotheses concerning the low smoking cessation rates in smokers with schizophrenia. The first hypothesis is that smokers with schizophrenia experience stronger and more sustained effects of smoking abstinence on negative mood and smoking urge than control smokers without psychiatric illness. The second hypothesis is that smokers with schizophrenia experience stronger reinforcing effects of a smoking lapse (i.e., more rewarding effects of smoking after a period of abstinence) than control smokers without psychiatric illness.

Detailed description

In this study, smokers with schizophrenia and smokers without psychiatric illness participate in a nicotine preference task before and after a 3-day period of continuous smoking abstinence. The investigators will experimentally control abstinence by providing participants with high-value cash incentives contingent upon smoking abstinence verified with breath carbon monoxide levels. The investigators will measure nicotine withdrawal and smoking urge during the abstinence period. In the nicotine preference task, participants will make choices between nicotine-containing and denicotinized cigarette puffs to provide a measure of nicotine reinforcement, and the investigators will also measure the effects of smoking on mood. After the second nicotine preference task, participants will receive a small-value reinforcer if they continue to abstain for another day, and the investigators will measure time to the second lapse.

Interventions

3 days of biologically-confirmed smoking abstinence

Sponsors

Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* cigarette smokers, 20-50 cigarettes per day * schizophrenia or no psychiatric illness * age 18 or older * male or female

Exclusion criteria

* unstable symptoms or medication * not interested in quitting smoking within 6 months

Design outcomes

Primary

MeasureTime frameDescription
Withdrawal symptoms3 daysnegative mood related to nicotine withdrawal
urge to smoke3 dayscraving for smoking
nicotine preferencebefore and after 3 days of abstinencechoice for nicotine puffs versus denicotinized cigarette puffs
positive and negative moodbefore and after 3 days of abstinencepositive and negative mood scale

Secondary

MeasureTime frameDescription
time to lapse192 hourstime between smoking behavior in the laboratory and first cigarette outside of the laboratory

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026